IP Library Granted Patent US 11,696,985
Granted Patent B2
US 11,696,985 · App. 16/863,824 · Granted Jul 11, 2023

Fluid therapy method

Inventors: Andrew V. Halpert (Brookline, MA); Mark Tauscher (Medfield, MA); Mark Gelfand (New York, NY); Howard Levin (Teaneck, NJ)
Assignee: Reprieve Cardiovascular, Inc.
A61M5/1723A61M2202/0496A61M2230/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,696,985
App. No.
16/863,824
Granted
Jul 11, 2023
Kind
B2
Abstract

A fluid therapy method for an ADHF patient includes setting a urine output rate desired threshold, setting one or more desired negative net gain rates, and optionally setting a total fluid loss goal. The urine output of the patient is monitored and fluid is automatically administered to the patient at increasing rates to equal to or approximately match the patient's increasing urine output rates until the patient's urine output rate reaches the set urine output rate desired threshold. Thereafter, fluid is administered to the patient at rates to achieve the set desired negative net gain rate until the fluid loss goal is reached. Thereafter, until the end of therapy, fluid is administered to the patient at rates equal to or approximately equal to the monitored urine output rates.

Claims (26)

1. A fluid therapy method comprising:

automatically measuring urine output of a patient;

automatically infusing a fluid intervascularly into the patient;

automatically controlling the infusion of the fluid to achieve a zero or positive fluid balance during a first period while a patient is being dosed with a diuretic and while the measured urine output of the patient is below a first threshold urine output level; and

after the measured urine output exceeds the first threshold urine output level, the automatic controlling of the infusion includes adjusting the infusion of the fluid to achieve a negative fluid balance during a second period following the first period.

2. The method of claim 1 , wherein the adjustment the infusion of the fluid includes reducing a rate of the infusion to less than a current rate of the measured urine output.

3. The method of claim 1 , further comprising inputting the first threshold urine output level to a computer which performs the automatic measuring of the urine, and the automatic controlling of the infusion of the fluid.

4. The method of claim 1 in which the fluid is saline or an osmotic solute.

5. The method of claim 1 in which the fluid is hypertonic saline.

6. The method of claim 1 , wherein the first threshold urine output level is a first threshold rate of urine output or a first threshold volume of urine output.

7. The method of claim 1 further including administering to the patient a diuretic while the fluid is infused and after the measured urine output exceeds a first threshold urine output level.

8. The method of claim 1 wherein the first threshold urine output level is a urine output rate of at least a liter an hour.

9. The method of claim 1 , in which the negative fluid balance is a positive difference between a current measured urine output level and a current infusion level of the fluid.

10. The method of claim 1 , in which the negative fluid balance is a positive difference between a current urine output rate and a current infusion rate of the fluid.

11. The method of claim 1 , wherein the negative fluid balance becomes progressively greater during the second period.

12. The method of claim 10 , wherein the negative fluid balance, during the second period, is initially 50 ml/hr and is later increased to at least 75 ml/hr.

13. The method of claim 1 , wherein the first threshold urine output is 400 ml/hr.

14. The method of claim 10 , wherein rate of the infusion of the fluid to achieve the negative fluid balance is determined as function of the measured urine output.

15. A method of treating a patient having excess fluid, the method comprising:

administering a diuretic to the patient to induce urine output by the patient;

for a first therapy period after beginning the diuretic administration, a controller infuses a fluid intravenously into the patient at a level matching or exceeding a current urine output level until the current urine output level reaches a first threshold urine output level; and

for a second therapy period after the urine output reaches the first threshold urine output level, the controller induces fluid loss in the patient by adjusting the infusion of the fluid to a level below the current urine output level.

16. The method of claim 15 , in which the negative fluid balance is a positive difference between the current urine output and a current infusion level of the fluid.

17. The method of claim 15 , wherein the negative fluid balance becomes progressively greater during the second period.

18. The method of claim 15 , wherein the negative fluid balance, during the second period, is initially 50 ml/hr and is later increased to at least 75 ml/hr.

19. The method of claim 15 , wherein the first threshold urine output level is a first threshold rate of urine output or a first threshold volume of urine output.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2020
From: CARDIORENAL SYSTEMS, INC.
To: REPRIEVE CARDIOVASCULAR, INC.
Reel/Frame 054044/0173 →
CHANGE OF NAME Recorded Oct 13, 2020
From: PLC MEDICAL SYSTEMS, INC.
To: RENALGUARD SOLUTIONS, INC.
Reel/Frame 054065/0310 →
CHANGE OF NAME Recorded Oct 13, 2020
From: RENALGUARD SOLUTIONS, INC.
To: CARDIORENAL SYSTEMS, INC.
Reel/Frame 054065/0313 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2020
From: HALPERT, ANDREW V.; TAUSCHER, MARK; GELFAND, MARK; LEVIN, HOWARD
To: PLC MEDICAL SYSTEMS, INC.
Reel/Frame 052652/0203 →
Continuity (4)
Continuation 16032453 · Jul 11, 2018
Continuation 14645730 · Mar 12, 2015
Provisional Application 61954089 · Mar 17, 2014
Related Publication 20200254178A1 · Aug 13, 2020
Cited By (7)
US 12,239,819 US 12,257,416 US 12,290,380 US 12,303,271 US 12,471,842 US 12,582,773 US 12,605,702